Inhibition of SIRT2 limits tumour angiogenesis via inactivation of the STAT3/VEGFA signalling pathway

Consensus guidelines for the use and interpretation of angiogenesis assays

(2018) Patrycja Nowak-Sliwinska et al.   ANGIOGENESIS

Promising New Agents for Colorectal Cancer

(2018) Satya Das et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

Resistance to Anti-Angiogenic Therapy in Cancer—Alterations to Anti-VEGF Pathway

(2018) Yoshiro Itatani et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Molecular subtyping of colorectal cancer: Recent progress, new challenges and emerging opportunities

(2018) Wei Wang et al.   SEMINARS IN CANCER BIOLOGY

ADAM12 Is a Novel Regulator of Tumor Angiogenesis via STAT3 Signaling

(2017) Roopali Roy et al.   MOLECULAR CANCER RESEARCH

Radiographic capsule-based system for non-cathartic colorectal cancer screening

(2017) Yoav Kimchy et al.   Abdominal Radiology

Exosomal Annexin II Promotes Angiogenesis and Breast Cancer Metastasis

(2016) Sayantan Maji et al.   MOLECULAR CANCER RESEARCH

Methylation-dependent regulation of HIF-1α stability restricts retinal and tumour angiogenesis

(2016) Yunho Kim et al.   Nature Communications

The SIRT2 Deacetylase Stabilizes Slug to Control Malignancy of Basal-like Breast Cancer

(2016) Wenhui Zhou et al.   Cell Reports

AK-1, a specific SIRT2 inhibitor, induces cell cycle arrest by downregulating Snail in HCT116 human colon carcinoma cells

(2015) Min Gyeong Cheon et al.   CANCER LETTERS

Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial

(2015) Christophe Tournigand et al.   LANCET ONCOLOGY

SIRT2: Tumour suppressor or tumour promoter in operable breast cancer?

(2013) Liane M. McGlynn et al.   EUROPEAN JOURNAL OF CANCER

SIRT2 overexpression in hepatocellular carcinoma mediates epithelial to mesenchymal transition by protein kinase B/glycogen synthase kinase-3β/β-catenin signaling

(2013) Juan Chen et al.   HEPATOLOGY

Three-Gene Immunohistochemical Panel Adds to Clinical Staging Algorithms to Predict Prognosis for Patients With Esophageal Adenocarcinoma

(2013) Chin-Ann J. Ong et al.   JOURNAL OF CLINICAL ONCOLOGY

SK-216, an Inhibitor of Plasminogen Activator Inhibitor-1, Limits Tumor Progression and Angiogenesis

(2013) Takeshi Masuda et al.   MOLECULAR CANCER THERAPEUTICS

Altered expression of SIRT gene family in head and neck squamous cell carcinoma

(2013) Chi-Chih Lai et al.   TUMOR BIOLOGY

SIRT2 Maintains Genome Integrity and Suppresses Tumorigenesis through Regulating APC/C Activity

(2011) Hyun-Seok Kim et al.   CANCER CELL

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Growing tumor vessels: More than one way to skin a cat – Implications for angiogenesis targeted cancer therapies

(2011) Rodrigo Leite de Oliveira et al.   MOLECULAR ASPECTS OF MEDICINE

HCC and angiogenesis: possible targets and future directions

(2011) Andrew X. Zhu et al.   Nature Reviews Clinical Oncology